MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-11-2026
Cronos Group EV/EBITDA Ratio 2011-2026 | CRON
Annual EV/EBITDA Ratio Cronos Group
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.428 | -2.37 | -0.492 | -3.92 | - | -14.5 | -9.74 | -255 | 423 | -102 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 423 | -255 | 4.01 |
EV/EBITDA Ratio of other stocks in the Drug manufacturers industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
-2.32 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
0.599 | - | - | $ 36.6 M |  USA |
 |
Cumberland Pharmaceuticals
CPIX
|
45.3 | $ 5.64 | 0.71 % | $ 83.8 M | USA |
 |
HEXO Corp.
HEXO
|
-0.524 | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
2.61 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
-0.504 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
0.585 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-1.21 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-18.4 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
-1.28 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
28.9 | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
-3.19 | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
69.4 | $ 39.42 | 4.72 % | $ 1.45 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-19 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
-64.3 | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
5.6 | - | -39.89 % | $ 27.7 M | USA |
 |
Organogenesis Holdings
ORGO
|
6.81 | $ 2.42 | 3.42 % | $ 307 M | USA |
 |
Canopy Growth Corporation
CGC
|
-4.28 | $ 1.01 | 1.0 % | $ 109 M | Canada |
 |
Pacira BioSciences
PCRX
|
29.6 | $ 23.05 | 0.24 % | $ 1.07 B | USA |
 |
Aurora Cannabis
ACB
|
66.7 | $ 3.08 | 1.16 % | $ 169 M | Canada |
 |
Solid Biosciences
SLDB
|
-3.47 | $ 7.41 | 3.71 % | $ 648 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-4.16 | $ 1.12 | 2.94 % | $ 1.39 M | USA |
 |
Jupiter Wellness
JUPW
|
5.65 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
-4.72 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
-4.08 | $ 1.04 | -1.89 % | $ 99.1 M | Canada |
 |
Tilray
TLRY
|
-46 | $ 5.08 | 1.91 % | $ 3.14 B | Canada |
 |
Evolus
EOLS
|
-9.74 | $ 6.78 | 0.74 % | $ 437 M | USA |
 |
Sundial Growers
SNDL
|
-1.27 | $ 1.42 | -0.1 % | $ 3.37 M | Canada |
 |
Emergent BioSolutions
EBS
|
5.32 | $ 8.31 | -0.12 % | $ 445 M | USA |
 |
Veru
VERU
|
-3.28 | $ 3.17 | 5.67 % | $ 46.4 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
0.799 | - | - | $ 193 M | Canada |
 |
cbdMD
YCBD
|
-2.5 | $ 0.7 | 2.06 % | $ 2.82 M | USA |
 |
Assertio Holdings
ASRT
|
28.1 | $ 23.5 | 0.06 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
-4.26 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
-13.5 | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
8.84 | $ 5.08 | 0.4 % | $ 1.88 B | Canada |
 |
PetIQ
PETQ
|
9.82 | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
-4.24 | $ 6.87 | 3.23 % | $ 271 M | USA |
 |
Recro Pharma
REPH
|
47.3 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
-5.28 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
-1.64 | $ 4.31 | 1.77 % | $ 215 M | USA |
 |
PLx Pharma
PLXP
|
-1.84 | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
157 | $ 16.4 | -0.52 % | $ 19.1 B | USA |
 |
Zomedica Corp.
ZOM
|
-0.0319 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
0.644 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
-17.3 | $ 0.66 | 6.29 % | $ 23.7 M | USA |
 |
Tricida
TCDA
|
-3.64 | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
-6.14 | $ 0.78 | 5.75 % | $ 3.35 M |  China |
 |
TherapeuticsMD
TXMD
|
-6.57 | $ 2.29 | 4.1 % | $ 26.5 M | USA |